Frontier Medicines

Company Overview

Frontier Medicines is a leading precision medicine company that is revolutionizing the field of drug discovery and development. With locations in both South San Francisco, CA and Boston, MA, Frontier Medicines is at the forefront of developing medicines against disease-causing proteins that were previously considered undruggable. Through our innovative discovery and development platform, we are able to identify and target the most important drivers of disease, ultimately bringing groundbreaking treatments to patients in need.

Using cutting-edge technologies in chemoproteomics, covalent drug discovery, and machine learning, Frontier Medicines is able to take a unique approach to drug development. By targeting proteins that were previously thought to be unreachable, we are able to create a pipeline of novel medicines that have the potential to make a significant impact on patient outcomes. Our lead program is focused on KRAS G12C, a driver in multiple types of cancer that until recently has been deemed undruggable. By targeting both the activated and inactive forms of this protein, we are paving the way for a new era in cancer treatment.

At Frontier Medicines, we are driven by our bold vision of advancing science to defeat disease. We are passionate about pushing the boundaries of what is possible in drug discovery and are committed to bringing hope to patients and their families. Through our innovative pipeline of precision medicines, we are taking on some of the most challenging diseases and working towards a future where they are no longer a threat.

Aside from our groundbreaking science, Frontier Medicines also prides itself on our strong company culture. We are a diverse team of scientists, researchers, and business professionals who are united by a common goal – to make a meaningful difference in the lives of patients. Our collaborative and inclusive environment fosters creativity and innovation, allowing us to push the limits of what is possible in drug discovery.